Nature

Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue

Throughout the last decades, the interaction between malignant cells and extracellular matrix (ECM) has been the object of intensive studies, with particular focus on the biochemical degradation of ...
ascopubs.org

MMP-9 expression as a predictor of tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy

No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO Annual Meeting. This abstract does not include a full text component.
BioWorld

Roche identifies MMP-9 inhibitors for dry eye

F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have patented 5-[2,7-diazaspiro[3.5]nonan-7-yl]-5-[4-phenoxyphenyl]hexahydropyrimidine-2,4,6-trione derivatives acting as matrix ...
GEN

EA Pharma Licenses MMP-9 mAb from Merck Serono Spin-Out, Calypso

Gastrointestinal drug development firm EA Pharma negotiated an exclusive, global license to develop, manufacture, and market Calypso Biotech’s preclinical-stage fully human anti-MMP-9 (matrix ...